Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
Eetgemak
Eetgemak is a leading producer and supplier of chilled meals, meal components, and dietary meals to the healthcare industry. The company supplies key institutions such as care homes, hospitals, schools and caterers, amongst others. Eetgemak delivers freshly prepared, healthier, and
Private Equity
Jecture
Jecture focuses on designing and contract manufacturing tailor-made, complex cannulas and cannula systems for pharmaceutical and medical applications. Headquartered in Germany, the group consists of the two well-established companies Acti-Med and EUROPIN – both with more than 25 years of
Private Equity
NIZO
NIZO is a state-of-the art, globally operating contract research organization for better food and health outcomes with headquarters in Ede, the Netherlands. It focuses on the development and application of innovative technologies for its customers in the global food industry
